Aemetis (NASDAQ:AMTX) Rating Lowered to “Sell” at Wall Street Zen

Aemetis (NASDAQ:AMTX) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday.

A number of other research firms also recently weighed in on AMTX. Loop Capital set a $1.75 price target on Aemetis in a research note on Thursday, March 12th. Ascendiant Capital Markets increased their price target on Aemetis from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a research note on Monday, April 20th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $8.92.

Aemetis Stock Down 8.5%

AMTX stock opened at $2.25 on Friday. The business’s fifty day moving average is $2.66 and its 200-day moving average is $2.00. The company has a market cap of $158.33 million, a P/E ratio of -1.89 and a beta of 1.36. Aemetis has a twelve month low of $1.30 and a twelve month high of $3.80.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The firm had revenue of $54.62 million during the quarter, compared to the consensus estimate of $66.70 million. Research analysts anticipate that Aemetis will post -1.03 earnings per share for the current fiscal year.

Institutional Trading of Aemetis

Several hedge funds have recently added to or reduced their stakes in AMTX. Royal Bank of Canada raised its stake in Aemetis by 10,632.5% during the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after buying an additional 8,825 shares during the period. Creative Planning acquired a new stake in Aemetis during the 2nd quarter worth $30,000. Virtu Financial LLC acquired a new stake in Aemetis during the 4th quarter worth $31,000. Sanctuary Advisors LLC acquired a new stake in Aemetis during the 1st quarter worth $33,000. Finally, HRT Financial LP acquired a new stake in Aemetis during the 4th quarter worth $36,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.